Investor Relations

Annual Shareholders Meeting 2014 – 7/30/14

CEO Mark Perrin and CSO Tom Ulich walk through the corporate presentation.


Analyst Coverage

Firm Analyst
Aegis Capital Raghuram Selvaraju

InVivo Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding InVivo’s Therapeutics performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of InVivo Therapeutics or its management. InVivo Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Latest News

Stock Chart

2012 Annual Report